Literature DB >> 22980946

[Assessment of electronic medical records. Relationship between process indicators measured using electronic records and intermediate health outcomes in patients with hypertension].

Gerardo Garzón González1, David Rodríguez Morales, Miguel Ángel Rodríguez Palomino, David Toledo Gómez, Valentín Hernández Barrera, Angel Gil De Miguel.   

Abstract

OBJECTIVE: To study relationship between institutional process indicators (measured using electronic records) and intermediate outcomes of patients with hypertension.
DESIGN: Cross-sectional epidemiological study.
SETTING: Primary Care Health District 1. Madrid. 2010. PATIENTS: All patients with hypertension. n=80,306. MAIN MEASUREMENTS: Variables. Independent. Institutional process indicators. Dependent. Intermediate outcomes: blood pressure within target limits, LDL-cholesterol, tobacco and weight and detected complications. Confounding. Age, gender, co-morbidity, drugs and professional variables.
RESULTS: The BP of 55.1% (SE 0.2%) of patients was within target limits. Bivariate analysis and multivariate logistic regression showed that the recording of some process indicators was associated with an increase in the probability to achieve targets in intermediate outcomes: smoking advice (OR: 1.69, 95% CI: 1.61 - 1.77), reviewing personal history (OR: 1.54, 95% CI:1.42-1.68), increase was less or biased: BP (OR: 1.19, 95% CI:1.14-1.25), sodium and potassium (OR: 1.14, 95% CI:1.09-1.19), BMI (OR 1.08, 95% CI:1.04-1.12); also diabetes, edema, and creatinine, but there was timing bias. The relationship between other indicators (those oriented to lifestyle, family history, classification, urine examination, reviewing of drug therapy, LDL, electrocardiogram and cardiac auscultation) and a higher probability to achieve targets was not found.
CONCLUSIONS: In hypertension, some institutional process indicators measured on electronic records were associated with an increase in the probability to achieve targets in intermediate outcomes. No relationship was found between other indicators. This suggests maintaining process and outcome measurement, to include the impact of interventions, to prioritize improvements in process indicators that show low performance and high impact and to remove or to change process indicators where no relationship is found.
Copyright © 2011 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22980946      PMCID: PMC7025619          DOI: 10.1016/j.aprim.2012.06.004

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  19 in total

1.  [2003 update of the Guidelines of the Spanish Society of Cardiology on High Blood Pressure].

Authors:  José Ramón González-Juanatey; Pilar Mazón Ramos; Federico Soria Arcos; Vivencio Barrios Alonso; Luis Rodríguez Padial; Vicente Bertomeu Martínez
Journal:  Rev Esp Cardiol       Date:  2003-05       Impact factor: 4.753

Review 2.  Epidemiology of uncontrolled hypertension in the United States.

Authors:  Thomas J Wang; Ramachandran S Vasan
Journal:  Circulation       Date:  2005-09-13       Impact factor: 29.690

Review 3.  Quality improvement strategies for hypertension management: a systematic review.

Authors:  Judith M E Walsh; Kathryn M McDonald; Kaveh G Shojania; Vandana Sundaram; Smita Nayak; Robyn Lewis; Douglas K Owens; Mary Kane Goldstein
Journal:  Med Care       Date:  2006-07       Impact factor: 2.983

4.  [Hypertension and health policy in Spain].

Authors:  José R Banegas; Albert Jovell; Benjamín Abarca; Manuel Aguilar Diosdado; Luis Aguilera; Pedro Aranda; Vicente Bertoméu; Pedro Capilla; Pedro Conthe; Fernando De Alvaro; Antonio Fernández-Pro; Xavier Formiguera; Jesús Frías; Lucía Guerrero; José L Llisterri; José M Lobos; Juan F Macías; Angel L Martín De Francisco; Jesús Millán; Juan C Morales; Vicente Palomo; Alex Roca-Cusachs; Javier Román; Carlos Sanchis; Antonio Sarriá; Julián Segura; Alex De La Sierra; Luis Verde; Julio Zarco; Luis M Ruilope
Journal:  Med Clin (Barc)       Date:  2009-02-12       Impact factor: 1.725

5.  [Process indicators and result indicators in the control of arterial hypertension].

Authors:  A Dalfó Baqué; A Sisó Almirall; M A Vila Coll; S Núñez Vázquez; M Botinas Martí; E Gibert Llorach
Journal:  Aten Primaria       Date:  2000-12       Impact factor: 1.137

6.  Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus.

Authors:  Nicolas Rodondi; Tiffany Peng; Andrew J Karter; Douglas C Bauer; Eric Vittinghoff; Simon Tang; Daniel Pettitt; Eve A Kerr; Joe V Selby
Journal:  Ann Intern Med       Date:  2006-04-04       Impact factor: 25.391

Review 7.  Advice to reduce dietary salt for prevention of cardiovascular disease.

Authors:  L Hooper; C Bartlett; Smith G Davey; S Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2004

8.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  Quality of care for hypertension in the United States.

Authors:  Steven M Asch; Elizabeth A McGlynn; Liisa Hiatt; John Adams; Jennifer Hicks; Alison DeCristofaro; Roland Chen; Pablo LaPuerta; Eve A Kerr
Journal:  BMC Cardiovasc Disord       Date:  2005-01-07       Impact factor: 2.298

10.  Effect of social deprivation on blood pressure monitoring and control in England: a survey of data from the quality and outcomes framework.

Authors:  Mark Ashworth; Jibby Medina; Myfanwy Morgan
Journal:  BMJ       Date:  2008-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.